TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32143725

Group type: EXPERIMENTAL
Intervention: ABM + real tDCS
Number of subjects: 30

Group type: COMPARATOR
Intervention: ABM + sham tDCS
Number of subjects: 30
Study: 33726315

Group type: EXPERIMENTAL
Intervention: Raman-based device for generating laser pulses with quantum-randomized polarizations
Number of subjects: 0
Study: 32073608

Group type: EXPERIMENTAL
Intervention: Low-calorie breakfast (11% of daily kilocalorie requirement)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High-calorie dinner (69% of daily kilocalorie requirement)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Breakfast (low-calorie)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Dinner (high-calorie)
Number of subjects: 16
Study: 33191871

Group type: EXPERIMENTAL
Intervention: Mind-body intervention
Number of subjects: 51

Group type: COMPARATOR
Intervention: Educational control
Number of subjects: 51
Study: 36085410

Group type: EXPERIMENTAL
Intervention: EndoRings assisted colonoscopy (ER)
Number of subjects: 556

Group type: COMPARATOR
Intervention: Standard colonoscopy (SC)
Number of subjects: 556
Study: 34406315

Group type: EXPERIMENTAL
Intervention: 5.25% NaOCI solution
Number of subjects: 114

Group type: COMPARATOR
Intervention: 5.25% NaOCI gel
Number of subjects: 114
Study: 36404630

Group type: EXPERIMENTAL
Intervention: RoFA mastectomy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard mastectomy
Number of subjects: 100
Study: 32419594

Group type: EXPERIMENTAL
Intervention: 8-mg intramuscular injections of a non-viral DNA plasmid
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: 16-mg intramuscular injections of a non-viral DNA plasmid
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study: 35751777

Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT4) solid formulation, 200 mcg orally administered at 08:00 h
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT4) liquid formulation, 200 mcg orally administered at 08:00 h
Number of subjects: 29
Study: 33539945

Group type: EXPERIMENTAL
Intervention: Ibrutinib plus nab-paclitaxel/gemcitabine
Number of subjects: 424

Group type: COMPARATOR
Intervention: Placebo plus nab-paclitaxel/gemcitabine
Number of subjects: 424
Study: 32659160

Group type: EXPERIMENTAL
Intervention: Matching Adjusted Indirect Comparison (MAIC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bucher
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulated Treatment Comparison (STC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MAIC and STC adjusted for confounders
Number of subjects: 0
Study: 36305113

Group type: EXPERIMENTAL
Intervention: ECG-guided positioning
Number of subjects: 120

Group type: COMPARATOR
Intervention: Body surface measurement and postoperative chest X-ray localization (Control)
Number of subjects: 120
Study: 33890449

Group type: EXPERIMENTAL
Intervention: Costoclavicular block (CC)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Lateral sagittal infraclavicular block (LS)
Number of subjects: 80
Study: 35761262

Group type: EXPERIMENTAL
Intervention: L‐HIIT (supervised)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: H‐HIIT (unsupervised)
Number of subjects: 30

Group type: COMPARATOR
Intervention: CON (no intervention)
Number of subjects: 30
Study: 33085801

Group type: EXPERIMENTAL
Intervention: Tailored pharmacist-led intervention based on adherence barriers (forgetfulness, lack of knowledge, lack of motivation, other drug-related problems)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 113
Study: 34705785

Group type: EXPERIMENTAL
Intervention: Patient-specific implants
Number of subjects: 64

Group type: COMPARATOR
Intervention: CAD/CAM surgical splints
Number of subjects: 64
Study: 32408551

Group type: EXPERIMENTAL
Intervention: Intervention group (69 families)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Enhanced control group (20 families)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Regular control group (70 families)
Number of subjects: 159
Study: 36239907

Group type: EXPERIMENTAL
Intervention: Home-based resistance and aerobic exercise (EX) for 12 weeks
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Home-based resistance and aerobic exercise (EX)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Usual care/control (CON)
Number of subjects: 106
Study: 33346683

Group type: EXPERIMENTAL
Intervention: Colchicine (25 nmol/L)
Number of subjects: 60
Study: 32087691

Group type: EXPERIMENTAL
Intervention: FSRT (Fractionated Stereotactic Radiotherapy)
Number of subjects: 0
Study: 36036889

Group type: EXPERIMENTAL
Intervention: Robotic APRs
Number of subjects: 347

Group type: COMPARATOR
Intervention: Laparoscopic APRs
Number of subjects: 347
Study: 33794498

Group type: EXPERIMENTAL
Intervention: Strip craniectomy (126 patients)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Cranial vault remodeling (79 patients)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Cranial vault remodeling with tranexamic acid
Number of subjects: 205

Group type: COMPARATOR
Intervention: Cranial vault remodeling without tranexamic acid
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Overall complication rates
Number of subjects: 205
Study: 32196793

Group type: EXPERIMENTAL
Intervention: DASH dietary pattern
Number of subjects: 511
Study: 35476143

Group type: EXPERIMENTAL
Intervention: Galcanezumab 300 mg subcutaneously every 4 weeks
Number of subjects: 343

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 343
Study: 33914595

Group type: EXPERIMENTAL
Intervention: Apalutamide plus ADT
Number of subjects: 1052

Group type: COMPARATOR
Intervention: Placebo plus ADT
Number of subjects: 1052
Study: 36726374

Group type: EXPERIMENTAL
Intervention: Most‐Liked Music (MLM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Least‐Liked Music (LLM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conditioned Pain Modulation (CPM)
Number of subjects: 0
Study: 35025542

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) and interpersonal psychotherapy (IPT)
Number of subjects: 159
Study: 32380950

Group type: EXPERIMENTAL
Intervention: Perturbation-based gait training on a treadmill, 4 weeks, two times per week, with simulated slips and trips and cognitive dual tasks.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Treadmill training under cognitive dual-task conditions without perturbations (Control group).
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups assessed on clinical balance and gait assessments, and questionnaires on falls- and gait-efficacy.
Number of subjects: 70
Study: 36112027

Group type: EXPERIMENTAL
Intervention: E-learning in postpartum haemorrhage and written course material in preeclampsia
Number of subjects: 45

Group type: COMPARATOR
Intervention: E-learning in preeclampsia and written course material in postpartum haemorrhage
Number of subjects: 45
Study: 34472114

Group type: EXPERIMENTAL
Intervention: CBT therapist-led (CBTth)
Number of subjects: 457

Group type: COMPARATOR
Intervention: CBT guided-self-help (CBTgsh)
Number of subjects: 457
Study: 32157242

Group type: EXPERIMENTAL
Intervention: 10 Gy/SF (single fraction)
Number of subjects: 112

Group type: COMPARATOR
Intervention: 20 Gy/5Fx (five fractions)
Number of subjects: 112
Study: 35576548

Group type: EXPERIMENTAL
Intervention: Multimodal opioid-sparing pain management protocol
Number of subjects: 90

Group type: COMPARATOR
Intervention: Traditional opioid-containing pain management protocol
Number of subjects: 90

Group type: COMPARATOR
Intervention: Traditional opioid-containing pain management protocol with additional local infiltration analgesia (LIA)
Number of subjects: 90
Study: 33852248

Group type: EXPERIMENTAL
Intervention: Oral sarecycline (once-daily, weight-based dosing)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control (multivitamin tablet)
Number of subjects: 102
Study: 32852531

Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg, weeks 1 and 3)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Nivolumab plus Ipilimumab (Ipilimumab 1 mg/kg, week 1 only)
Number of subjects: 29
Study: 35685982

Group type: EXPERIMENTAL
Intervention: Allograft patch augmentation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (arthroscopic rotator cuff repair)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Allograft group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (CC subgroup)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Allograft group (CC subgroup)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (Constant and ASES scores)
Number of subjects: 60
Study: 34556670

Group type: EXPERIMENTAL
Intervention: Berberine (BBR)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 33021891

Group type: COMPARATOR
Intervention: Standard protocol (10-mm slabs with 5-mm overlap, 1-mm slices, synthetic 2D mammogram)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Experimental protocol (6-mm slabs with 3-mm overlap, synthetic 2D mammogram)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Experimental protocol (6-mm slabs with 3-mm overlap)
Number of subjects: 122
Study: 36213912

Group type: EXPERIMENTAL
Intervention: Fear-focused Self-compassion Therapy
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 160
Study: 33371726

Group type: EXPERIMENTAL
Intervention: Focusing on Maryam's flower during labor
Number of subjects: 124
Study: 32102708

Group type: EXPERIMENTAL
Intervention: Giardia spp. detection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other enteric pathogens (Salmonella enterica, enterotoxigenic E. coli, Shigella spp.)
Number of subjects: 0
Study: 35261279

Group type: EXPERIMENTAL
Intervention: Icosapent ethyl
Number of subjects: 3408

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3408
Study: 36330499

Group type: EXPERIMENTAL
Intervention: Adjuvant gemcitabine (LT-Gem group)
Number of subjects: 12

Group type: COMPARATOR
Intervention: LT alone (LT alone group)
Number of subjects: 12
Study: 32951999

Group type: EXPERIMENTAL
Intervention: Sublingual sufentanil tablet system
Number of subjects: 64

Group type: COMPARATOR
Intervention: Nurse-controlled continuous morphine infusion
Number of subjects: 64
Study: 32700158

Group type: EXPERIMENTAL
Intervention: Ustekinumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Partial Mayo score
Number of subjects: 0
Study: 35583544

Group type: EXPERIMENTAL
Intervention: 0° lateral view
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: -15° rollunder lateral view
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard posteroanterior view
Number of subjects: 10
Study: 34768614

Group type: EXPERIMENTAL
Intervention: SCS + PNfS
Number of subjects: 14

Group type: COMPARATOR
Intervention: SCS only
Number of subjects: 14
Study: 35443302

Group type: EXPERIMENTAL
Intervention: Nutrition Improvement Program for Rural Compulsory Education Students
Number of subjects: 1550969
Study: 34536693

Group type: EXPERIMENTAL
Intervention: Soft-soled sandals
Number of subjects: 47

Group type: COMPARATOR
Intervention: Hard-soled sandals
Number of subjects: 47

Group type: COMPARATOR
Intervention: Soft-soled runners
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Hard-soled runners
Number of subjects: 47

Group type: COMPARATOR
Intervention: Soft-soled boots
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Hard-soled boots
Number of subjects: 47
Study: 36405599

Group type: EXPERIMENTAL
Intervention: Yijinjing combined with elastic band exercise (5 times a week for 6 months)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Yijinjing combined with elastic band exercise
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (maintained original lifestyle)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 47
Study: 32842248

Group type: EXPERIMENTAL
Intervention: Intrauterine balloon tamponade
Number of subjects: 161

Group type: COMPARATOR
Intervention: Gauze packing
Number of subjects: 161
Study: 32993441

Group type: EXPERIMENTAL
Intervention: Values comprising 'Self-Enhancement' and 'Openness to Change'
Number of subjects: 0

Group type: COMPARATOR
Intervention: Values comprising 'Self-Transcendence' and 'Conservation'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Compulsive buyers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Values emphasizing importance of communal goals
Number of subjects: 0
Study: 36166094

Group type: EXPERIMENTAL
Intervention: Fixed valgus angle distal femur resection (5-degree valgus correction)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Variable valgus angle distal femur resection (individualized valgus correction angle)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both groups (fixed and variable angle)
Number of subjects: 49
Study: 32886131

Group type: EXPERIMENTAL
Intervention: Physiological ischemic training (PIT)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Conventional drug treatment (Control)
Number of subjects: 165
Study: 32594760

Group type: EXPERIMENTAL
Intervention: Vasoactive intestinal polypeptide (VIP) infusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 34088532

Group type: EXPERIMENTAL
Intervention: Physician guidance (PG)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 32
Study: 32907777

Group type: EXPERIMENTAL
Intervention: Apalutamide (240mg/d)
Number of subjects: 1207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1207
Study: 32994261

Group type: EXPERIMENTAL
Intervention: Rinsing and gargling mouthwash
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Rinsing duration
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Gargling duration
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Total duration of mouthwash use
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Duration of mouthwash use by group
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Mouthwash duration comparison by gender
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Volume of mouthwash used
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Dilution of mouthwash
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Comparison to randomized trial
Number of subjects: 200
Study: 36181063

Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 0
Study: 33852571

Group type: EXPERIMENTAL
Intervention: EPIC tool
Number of subjects: 1092

Group type: EXPERIMENTAL
Intervention: OLS models
Number of subjects: 1092

Group type: EXPERIMENTAL
Intervention: Best model fit
Number of subjects: 1092
Study: 32132224

Group type: EXPERIMENTAL
Intervention: Fingolimod
Number of subjects: 215
Study: 35216603

Group type: EXPERIMENTAL
Intervention: High robotic assistance group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low robotic assistance group
Number of subjects: 30
Study: 32144013

Group type: EXPERIMENTAL
Intervention: Open aortic repair (OAR)
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: OAR-only practice
Number of subjects: 702
Study: 36286675

Group type: EXPERIMENTAL
Intervention: Remaxol (400 ml/day)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Heptral (800 mg/day)
Number of subjects: 317
Study: 32915426

Group type: EXPERIMENTAL
Intervention: Dingkun Pill (7 g daily for 21 days, followed by 7 drug-free days)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Diane‐35 (1 tablet daily for 21 days, followed by 7 drug-free days)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Combined group (Dingkun Pill and Diane‐35)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 117
Study: 35829672

Group type: EXPERIMENTAL
Intervention: Bimekizumab 160 mg every 4 weeks
Number of subjects: 303
Study: 33410228

Group type: EXPERIMENTAL
Intervention: ESWT plus low-dye KT
Number of subjects: 45

Group type: COMPARATOR
Intervention: ESWT plus Sham-taping
Number of subjects: 45

Group type: COMPARATOR
Intervention: ESWT only
Number of subjects: 45
Study: 32600358

Group type: EXPERIMENTAL
Intervention: SPP (12‐15 mmHg) + deep‐NMB (post‐tetanic count of 1‐2)
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: LPP (7‐10 mmHg) + deep‐NMB
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: SPP + moderate‐NMB (train‐of‐four of 1‐2)
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: LPP + moderate‐NMB
Number of subjects: 648

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 648
Study: 35176639

Group type: EXPERIMENTAL
Intervention: Cold exercise intervention (5 °C)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Thermoneutral exercise intervention (15 °C)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 21
Study: 33314392

Group type: EXPERIMENTAL
Intervention: Newly established review criteria for hematology analyzers
Number of subjects: 1003

Group type: EXPERIMENTAL
Intervention: Validation of newly established criteria
Number of subjects: 1003

Group type: COMPARATOR
Intervention: ICGH criteria (control)
Number of subjects: 1003
Study: 36545533

Group type: EXPERIMENTAL
Intervention: Photobiomodulation group (PBMG)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 34
Study: 33853639

Group type: EXPERIMENTAL
Intervention: Atorvastatin treatment
Number of subjects: 384

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 384
Study: 34625954

Group type: EXPERIMENTAL
Intervention: Active surveillance
Number of subjects: 1638

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 1638
Study: 33169699

Group type: EXPERIMENTAL
Intervention: 30-min aerobic exercise at moderate intensity
Number of subjects: 49

Group type: COMPARATOR
Intervention: Relaxation (control group)
Number of subjects: 49
Study: 32418547

Group type: EXPERIMENTAL
Intervention: Decaffeinated coffee with milk and sugar
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Black coffee
Number of subjects: 21

Group type: COMPARATOR
Intervention: Water
Number of subjects: 21
Study: 35005040

Group type: EXPERIMENTAL
Intervention: Meaning-centered play intervention, implemented in twelve 45-minute sessions, twice a week for six weeks.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual trend of the center's plays and programs (Control group).
Number of subjects: 120
Study: 32680943

Group type: EXPERIMENTAL
Intervention: Genetically predicted average accelerations
Number of subjects: 63926

Group type: EXPERIMENTAL
Intervention: Genetic liability for fraction of accelerations >425 milligravities
Number of subjects: 63926
Study: 36011781

Group type: EXPERIMENTAL
Intervention: Hungarian version of SCREENIVF
Number of subjects: 60

Group type: COMPARATOR
Intervention: FertiQoL
Number of subjects: 60
Study: 33438516

Group type: EXPERIMENTAL
Intervention: High-salt diet (HS; 250 mEq sodium/day)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Low-salt diet (LS; 50 mEq sodium/day)
Number of subjects: 9
Study: 32646743

Group type: EXPERIMENTAL
Intervention: Coronary artery calcium scoring
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Deferral of statin therapy
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Coronary artery calcium scoring in women 50 years and older
Number of subjects: 1000
Study: 33939143

Group type: EXPERIMENTAL
Intervention: Hunger-based feeding
Number of subjects: 110

Group type: COMPARATOR
Intervention: Conventional feeding
Number of subjects: 110
Study: 33236676

Group type: EXPERIMENTAL
Intervention: Drug therapy problems (adverse drug reactions)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Gastrointestinal problems
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Cardiovascular diseases
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Psychological health score
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Anemia presence
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Coverage
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Cardiovascular problems
Number of subjects: 71
Study: 32898792

Group type: EXPERIMENTAL
Intervention: Switch maintenance chemotherapy (pemetrexed 500 mg/m2 d1, 22 for non-squamous cell carcinoma; gemcitabine 1,150 mg/m2 d1, 8, 22 for squamous cell carcinoma)
Number of subjects: 328

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Switch maintenance chemotherapy
Number of subjects: 328
Study: 35953245

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: NPH insulin two times per day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 20

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 20
Study: 33196083

Group type: EXPERIMENTAL
Intervention: Visual cues on packaging (salient labeled stripes)
Number of subjects: 927

Group type: COMPARATOR
Intervention: Control condition (no visual cues)
Number of subjects: 927
Study: 32152868

Group type: EXPERIMENTAL
Intervention: Brief Behavioral Therapy for Insomnia (BBT-I)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Self-monitoring control
Number of subjects: 25
Study: 35060404

Group type: EXPERIMENTAL
Intervention: Single-session Acceptance and Commitment Therapy intervention (<3 hours)
Number of subjects: 15
Study: 33483850

Group type: EXPERIMENTAL
Intervention: Self-arousal group (participants rated willingness to have sex with a condom if their own arousal decreased from 100 to 10%)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Partner-arousal group (participants rated willingness to have sex with a condom if their partner's arousal decreased from 100 to 10%)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Men (vs. women) in the most desirable partner condition
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Higher arousal discounting
Number of subjects: 379
Study: 34392376

Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-smokers
Number of subjects: 0

Group type: COMPARATOR
Intervention: BMI categories
Number of subjects: 0

Group type: COMPARATOR
Intervention: Smoking status
Number of subjects: 0

Group type: COMPARATOR
Intervention: BMI
Number of subjects: 0
Study: 34313874

Group type: EXPERIMENTAL
Intervention: Screening group
Number of subjects: 80149

Group type: EXPERIMENTAL
Intervention: T1c tumor diagnosis rates
Number of subjects: 80149

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80149
Study: 32554365

Group type: EXPERIMENTAL
Intervention: Periarticular injection of 20 mL 0.5% bupivacaine HCl (100 mg) after implantation
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combined periarticular injection of 20 mL 0.5% bupivacaine HCl (100 mg) and incisional injection of 10 mL 0.5% bupivacaine HCl (50 mg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: No injection (control group)
Number of subjects: 90